参考文献/References:
[1]Kwon DI,Miles BA,Education Committee of the American Head and Neck Society (AHNS).Hypopharyngeal carcinoma:Do you know your guidelines?[J].Head Neck,2019,41(3):569-576.[2]Bradley PJ.Epidemiology of Hypopharyngeal Cancer[J].Adv Otorhinolaryngol,2019(83):1-14.[3]Yin CY,Zhang SS,Zhong JT,et al.Pepsin and Laryngeal and Hypopharyngeal Carcinomas[J].Clin Exp Otorhinolaryngol,2021,14(2):159-168.[4]中华耳鼻咽喉头颈外科杂志编辑委员会咽喉组,中华医学会耳鼻咽喉头颈外科学分会咽喉学组.咽喉反流性疾病诊断与治疗专家共识(2015年)[J].中华耳鼻咽喉头颈外科杂志,2016,51(5):324-326.[5]Brown J,Shermetaro C.Laryngopharyngeal Reflux[M].In: StatPearls.Treasure Island(FL):StatPearls Publishing,2020.[6]鲁明,陈贤明.咽喉反流与上下呼吸道疾病[J].国际耳鼻咽喉头颈外科杂志,2017,41(5):266-269.[7]Tseng WH,Hsu WC,Hsiao TY,et al.Anatomical and physiological characteristics in patients with Laryngopharyngeal Reflux Symptoms:A case-control study utilizing high-resolution impedance manometry[J].J Formos Med Assoc,2022,121(6):1034-1043.[8]Tack J,Pandolfino JE.Pathophysiology of Gastroesophageal Reflux Disease[J].Gastroenterology,2018,154(2):277-288.[9]Calvo-Henríquez C,Ruano-Ravina A,Vaamonde P,et al.Is Pepsin a Reliable Marker of Laryngopharyngeal Reflux? A Systematic Review[J].Otolaryngol Head Neck Surg,2017,157(3):385-391.[10]Samuels TL,Johnston N.Pepsin as a causal agent of inflammation during nonacidic reflux[J].Otolaryngol Head Neck Surg,2009,141(5):559-563.[11]Niu K,Guo C,Teng S,et al.Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation[J].PLoS One,2020,15(1):e0227408.[12]Koufman JA.Laryngopharyngeal reflux is different from classic gastroesophageal reflux disease[J].Ear Nose Throat J,2002,81(9 Suppl 2):7-9.[13]Doukas PG,Vageli DP,Sasaki CT,et al.Pepsin promotes activation of epidermal growth factor receptor and downstream oncogenic pathways, at slightly acidic and neutral pH, in exposed hypopharyngeal cells[J].Int J Mol Sci,2021,22(8):4275.[14]Zhao YY,Yu GT,Xiao T,et al.The Notch signaling pathway in head and neck squamous cell carcinoma: A meta-analysis[J].Adv Clin Exp Med,2017,26(5):881-887.[15]Reichel O,Mayr D,Durst F,et al.E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux[J].Eur Arch Otorhinolaryngol,2008,265(8):937-942.[16]Tan JJ,Wang L,Mo TT,et al.Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma[J].Cancer Cell Int,2019(19):64.[17]Sasaki CT,Hajek M,Doukas SG,et al.The role of bile reflux and its related NF-κB activated pathway in progression of hypopharyngeal squamous cell cancer[J].Oral Oncology,2020(105):104668.[18]Sasaki CT,Doukas SG,Costa J,et al.The Progressive mutagenic effects of acidic bile refluxate in hypopharyngeal squamous cell carcinogenesis:new insights[J].Cancers(Basel),2020,12(5):1064.[19]Vageli DP,Doukas SG,Spock T,et al.Curcumin prevents the bile reflux-induced NF-κB-related mRNA oncogenic phenotype,in human hypopharyngeal cells[J].J Cell Mol Med,2018,22(9):4209-4220.[20]Lechien JR,Huet K,Khalife M,et al.Alkaline, protein, low-fat and low-acid diet in laryngopharyngeal reflux disease: Our experience on 65 patients[J].Clin Otolaryngol,2019,44(3):379-384.[21]Salihefendic N,Zildzic M,Cabric E.Laryngopharyngeal Reflux Disease-LPRD[J].Med Arch,2017,71(3):215-218.[22]He C,Yu J,Huang F,et al.The utility of narrow band imaging in endoscopic diagnosis of laryngopharyngeal reflux[J].Am J Otolaryngol,2019,40(5):715-719.[23]Guo L,Liu Y.Narrow-band imaging combined with salivary pepsin to diagnose patients with laryngopharyngeal reflux[J].Acta Otolaryngol,2021,141(8):796-801.[24]Kim SI,Kwon OE,Na SY,et al.Association between 24-hour combined multichannel intraluminal impedance-pH monitoring and symptoms or quality of life in patients with laryngopharyngeal reflux[J].Clin Otolaryngol,2017,42(3):584-591.[25]Wang CP,Wang CC,Lien HC,et al.Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux[J].Laryngoscope,2019,129(3):709-714.[26]齐智伟,张淑君,张学红,等.3种方法诊断儿童咽喉反流的比较研究[J].临床耳鼻咽喉头颈外科杂志,2019,34(4):343-345.[27]Liu X,Jiang Y,Luo H,et al.Proton pump inhibitors for the treatment of laryngopharyngeal reflux disease: A protocol for systematic review and meta-analysis[J].Medicine(Baltimore),2020,99(49):e23297.[28]Belafsky PC,Postma GN,Koufman JA.The Validity and Reliability of the Reflux Finding Score (RFS)[J].The Laryngoscope,2001(111):1313-1317.[29]Belafsky PC,Postma GN,Koufman JA.Validity and reliability of the reflux symptom index (RSI)[J].Journal of Voice,2002,16(2):274-277.[30]Garneau JC,Bakst RL,Miles BA.Hypopharyngeal cancer: A state of the art review[J].Oral Oncol,2018,86(9):244-250.[31]Doukas SG,Cardoso B,Tower JI,et al.Biliary tumorigenic effect on hypopharyngeal cells is significantly enhanced by pH reduction[J].Cancer Med,2019,8(9):4417-4427.[32]Parsel SM,Wu EL,Riley CA,et al.Gastroesophageal and laryngopharyngeal reflux associated with laryngeal malignancy: systematic review and meta-analysis[J].Clin Gastroenterol Hepatol,2019,17(7):1253-1264.[33]Huestis MJ,Keefe KR,Kahn CI,et al.Alternatives to acid suppression treatment for laryngopharyngeal reflux[J].Ann Otol Rhinol Laryngol,2020,129(10):1030-1039.[34]Pracy P,Loughran S,Good J,et al.Hypopharyngeal cancer: United Kingdom national multidisciplinary guidelines[J].J Laryngol Otol,2016,130(S2):S104-S110.